Avidity Biosciences Inc
RNA
Market Cap$5.99B
Close$
$-1.75
103.6% downside
Current Fair Value
103.6% downsideOvervalued by 103.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.99 Billion |
|---|---|
| Enterprise Value | $5.77 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.89 |
| Beta | 0.95 |
| Outstanding Shares | 129,622,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.25 |
|---|---|
| PEG | -10.84 |
| Price to Sales | - |
| Price to Book Ratio | 5.39 |
| Enterprise Value to Revenue | 537.67 |
| Enterprise Value to EBIT | -11.04 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data